AMERIPRISE FINANCIAL INC
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in PHAT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,824,372
-$257,120 QoQ
Shares Held
254,219
+36.9% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,232,542,246 across 191 Biotechnology names. PHAT ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in PHAT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,824,372 | 254,219 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,081,492 | 185,744 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,527,523 | 554,590 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,734,360 | 180,851 | Shares | Defined | 2025-08-14 | |
| 2023-12-31 | $750,887 | 82,244 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $118,238 | 11,402 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||